Association of Asian ethnicity with disease activity in SLE: An observational study from the Monash Lupus Clinic

Lupus

Volumn 22, Issue 13, 2013, Pages 1425-1430

  Golder, V ^a   Connelly, K ^a   Staples, M ^a   Morand, E ^a   Hoi, A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

anti DNA antibodies; renal lupus; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; LA ANTIBODY; MYCOPHENOLIC ACID; PREDNISOLONE; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY;

ADULT; ARTICLE; DISEASE ACTIVITY; ETHNIC GROUP; ETHNICITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-DNA ANTIBODIES; RENAL LUPUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COMPLEMENT SYSTEM PROTEINS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VICTORIA;

EID: 84887099671     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313500547     Document Type: Article

References (32)

1. Alarcón GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998 ; 41: 1173-1180
2. Thumboo J, Fong KY, Chng HH, et al. The effects of ethnicity on disease patterns in 472 Orientals with systemic lupus erythematosus. J Rheumatol. 1998 ; 25: 1299-1304
3. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 ; 39: 257-268
4. Bossingham D. Systemic lupus erythematosus in the far north of Queensland. Lupus. 2003 ; 12: 327-331
5. Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: Prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken). 2012 ; 64: 159-168
6. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period. Medicine (Baltimore). 2003 ; 82: 299-308
7. Mason JA, Bossingham D. The clinical characterisation of systemic lupus erythematosus in a Far North Queensland indigenous kindred. Lupus. 2009 ; 18: 144-148
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
9. Yazdany J, Gillis JZ, Trupin L, et al. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Arthritis Rheum. 2007 ; 57: 593-600
10. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2550-2558
11. Touma Z, Urowitz M, Gladman D. SLEDAI-2K for a 30-day window. Lupus. 2010 ; 19: 49-51
12. Ibañez D, Urowitz MB, Gladman DD. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. J Rheumatol. 2003 ; 30: 1977-1982
13. Nikpour M, Urowitz MB, Ibañez D, Gladman DD. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus. Arthritis Rheum. 2009 ; 61: 1152-1158
14. Gladman DD, Urowitz MB, Rahman P, Ibañez D, Tam LS. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol. 2003 ; 30: 1955-1959
15. Connelly K, Morand EF, Hoi AY. Asian ethnicity in systemic lupus erythematosus: an Australian perspective. Intern Med J 2013; 43: 618-624.
16. Feng PH, Boey ML. Systemic lupus erythematosus in Chinese: The Singapore experience. Rheumatol Int. 1982 ; 2: 151-154
17. Wang F, Wang CL, Tan CT, Manivasagar M. Systemic lupus erythematosus in Malaysia: A study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus. 1997 ; 6: 248-253
18. Mok CC, Lau CS. Lupus in Hong Kong Chinese. Lupus. 2003 ; 12: 717-722
19. Thumboo J, Uramoto K, O'Fallon WM, et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Care & Research. 2001 ; 45: 494-500
20. Johnson SR, Urowitz MB, Ibañez D, Gladman DD. Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J Rheumatol. 2006 ; 33: 1990-1995
21. Peschken CA, Katz SJ, Silverman E, et al. The 1000 Canadian faces of lupus: Determinants of disease outcome in a large multiethnic cohort. J Rheumatol. 2009 ; 36: 1200-1208
22. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis. 1991 ; 50: 490-492
23. Boers A, Li Q, Wong M, Miller M, Littlejohn G. Differences in SLE disease activity between patients of Caucasian and South-East Asian/Chinese background in an Australian hospital. APLAR Journal of Rheumatology. 2006 ; 9: 43-48
24. Seligman VA, Lum RF, Olson JL, Li H, Criswell LA. Demographic differences in the development of lupus nephritis: A retrospective analysis. Am J Med. 2002 ; 112: 726-729
25. van Vollenhoven RF, Petri MA, Cervera R, et al. Belimumab in the treatment of systemic lupus erythematosus: High disease activity predictors of response. Ann Rheum Dis. 2012 ; 71: 1343-1349
26. Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol. 1998 ; 16: 261-292
27. Vuyyuru R, Mohan C, Manser T, Rahman ZSM. The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints. J Immunol. 2009 ; 183: 5716-5727
28. Sánchez E, Nadig A, Richardson BC, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011 ; 70: 1752-1757
29. Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009 ; 41: 1234-1237
30. Li LH, Yuan H, Pan HF, Li WX, Li XP, Ye DQ. Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta-analysis. Scand J Rheumatol. 2010 ; 39: 148-154
31. Liu K, Li QZ, Yu Y, et al. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun. 2007 ; 8: 634-645
32. Ye DQ, Yang SG, Li XP, et al. Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus. Arch Dermatol Res. 2005 ; 297: 108-113